Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron add-on to risperidone for cognitive impairment in schizophrenia
ChiCTR1900022365Phase 4Not yet recruiting
- Sponsor
- Beijing Anding Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tropisetron in schizophrenia (2 arms), sponsored by Beijing Anding Hospital. Primary endpoints: MATRICS Consensus Cognitive Battery and prepulse inhibition. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
tropisetron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR1900022365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022365.